What Do We (Not) Know About Global Views of Human Gene Editing? Insights and Blind Spots in the CRISPR Era.


Journal

The CRISPR journal
ISSN: 2573-1602
Titre abrégé: CRISPR J
Pays: United States
ID NLM: 101738191

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 9 2 2021
pubmed: 10 2 2021
medline: 8 9 2021
Statut: ppublish

Résumé

As research on human applications of CRISPR advances, researchers, advisory bodies, and other stakeholder organizations continue calling for global public discourses and engagement to shape the development of human gene editing (HGE). Research that captures public views and tests ways for engaging across viewpoints is vital for facilitating these discourses. Unfortunately, such research lags behind advances in HGE research and applications. Here, we provide the first review of nationally representative public-opinion surveys focused on HGE to discuss limitations and remaining gaps, illustrating how these gaps hinder interpretation of existing studies. Rigorous research with proper methods for capturing representative public opinion of HGE is limited, especially in countries outside of the United States and on a global scale. The result is severely restricted understanding of even the surface level of public views concerning HGE. We identify broad areas where we need more and better research capturing public views, and describe how future surveys can help collect insights necessary for discourse and decision making on HGE.

Identifiants

pubmed: 33560915
doi: 10.1089/crispr.2020.0004
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-155

Auteurs

Emily L Howell (EL)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Shiyu Yang (S)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Becca Beets (B)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Dominique Brossard (D)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Dietram A Scheufele (DA)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Michael A Xenos (MA)

Department of Life Sciences Communication, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH